Ivan Li 9/12/23 Ivan Li 9/12/23 CorVista Health Announces FDA Clearance of the Novel CorVista System to Detect the Presence of Cardiac Disease Read More Ivan Li 5/3/23 Ivan Li 5/3/23 Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity Read More Ivan Li 10/25/22 Ivan Li 10/25/22 CorVista Health Receives Breakthrough Device Designation for The CorVista® System Read More Ivan Li 9/15/22 Ivan Li 9/15/22 Great Bay Bio, a Hong Kong CRO, Closes $15 Million Round for AI-based Bioprocessing Read More Ivan Li 5/25/22 Ivan Li 5/25/22 Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer Read More Ivan Li 5/5/22 Ivan Li 5/5/22 Glen McLaughlin, Ph.D., Joins YorLabs as President and Chief Executive Officer Read More Ivan Li 5/3/22 Ivan Li 5/3/22 San Diego’s Cardea Bio nets Gates Foundation grant to uncover COVID, malaria and other diseases via breath Read More Ivan Li 3/15/22 Ivan Li 3/15/22 Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications Read More Ivan Li 1/18/22 Ivan Li 1/18/22 CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer Read More Ivan Li 1/10/22 Ivan Li 1/10/22 Cardea Bio announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications Read More Ivan Li 12/21/21 Ivan Li 12/21/21 Biotech company Senti Bio to go public via $600 mln SPAC deal Read More Ivan Li 10/28/21 Ivan Li 10/28/21 Dr. Kiana Aran of Cardea Bio wins the 2021 Nature Research Award for Scientific Achievement Read More Ivan Li 3/4/21 Ivan Li 3/4/21 CorVista Health Completes $65 Million Series C Equity Raise Bringing Total Funding to Nearly $100 Million Read More Ivan Li 1/12/21 Ivan Li 1/12/21 Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million Read More Ivan Li 1/6/21 Ivan Li 1/6/21 Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio Read More Ivan Li 10/5/20 Ivan Li 10/5/20 Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC Read More Ivan Li 1/22/20 Ivan Li 1/22/20 MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator Read More Ivan Li 1/13/20 Ivan Li 1/13/20 Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care Read More
Ivan Li 9/12/23 Ivan Li 9/12/23 CorVista Health Announces FDA Clearance of the Novel CorVista System to Detect the Presence of Cardiac Disease Read More
Ivan Li 5/3/23 Ivan Li 5/3/23 Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity Read More
Ivan Li 10/25/22 Ivan Li 10/25/22 CorVista Health Receives Breakthrough Device Designation for The CorVista® System Read More
Ivan Li 9/15/22 Ivan Li 9/15/22 Great Bay Bio, a Hong Kong CRO, Closes $15 Million Round for AI-based Bioprocessing Read More
Ivan Li 5/25/22 Ivan Li 5/25/22 Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer Read More
Ivan Li 5/5/22 Ivan Li 5/5/22 Glen McLaughlin, Ph.D., Joins YorLabs as President and Chief Executive Officer Read More
Ivan Li 5/3/22 Ivan Li 5/3/22 San Diego’s Cardea Bio nets Gates Foundation grant to uncover COVID, malaria and other diseases via breath Read More
Ivan Li 3/15/22 Ivan Li 3/15/22 Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications Read More
Ivan Li 1/18/22 Ivan Li 1/18/22 CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer Read More
Ivan Li 1/10/22 Ivan Li 1/10/22 Cardea Bio announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications Read More
Ivan Li 12/21/21 Ivan Li 12/21/21 Biotech company Senti Bio to go public via $600 mln SPAC deal Read More
Ivan Li 10/28/21 Ivan Li 10/28/21 Dr. Kiana Aran of Cardea Bio wins the 2021 Nature Research Award for Scientific Achievement Read More
Ivan Li 3/4/21 Ivan Li 3/4/21 CorVista Health Completes $65 Million Series C Equity Raise Bringing Total Funding to Nearly $100 Million Read More
Ivan Li 1/12/21 Ivan Li 1/12/21 Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million Read More
Ivan Li 1/6/21 Ivan Li 1/6/21 Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio Read More
Ivan Li 10/5/20 Ivan Li 10/5/20 Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC Read More
Ivan Li 1/22/20 Ivan Li 1/22/20 MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator Read More
Ivan Li 1/13/20 Ivan Li 1/13/20 Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care Read More
